short term use of semaglutide FDA alerts health care providers, compounders and patients dosing errors associated with compounded injectable products Semaglutide for Weight Loss: A

Abdominal obesity is linked with lower FVC and FEV1 and more airway closure in lower lung regions

I did a deep dive into all the research and as much of the biology as I can understand and I have a link to that research below

How Semaglutide Works Semaglutide acts on GLP-1 receptors throughout the body to: Increase insulin secretion after meals Reduce glucagon release from the liver Slow stomach emptying for longer satiety Suppress appetite via brain signaling These mechanisms make semaglutide effective for blood sugar control and weight management

Slowing Down Digestion: Semaglutide also slows down how quickly food leaves your stomach

Updated June 2025) An article for participants in the myCAMprogram Jan Semenoff, BA, EMA Forensic Criminalist This is an important article, as the use of Semaglutide, liraglutide and tirzepatide are now quite common as a weight control measure

Subsequently, three scores were calculated: (the Lower Body Pain Score (LBPS), the Upper Body Pain Score (UBPS) and the Total body pain score or RicolfiPatton Score (RPS), as described in our previous work [36]